When.com Web Search

  1. Ads

    related to: cholesterol absorption inhibitor side effects
    • Co-Pay Program

      Resources

      to Support Your Patients

    • Safety

      Safety Profile - Learn About

      Adverse Patient Reactions

Search results

  1. Results From The WOW.Com Content Network
  2. Ezetimibe - Wikipedia

    en.wikipedia.org/wiki/Ezetimibe

    Serious side effects may include anaphylaxis, liver problems, depression, and muscle breakdown. [4] [5] Use in pregnancy and breastfeeding is of unclear safety. [10] Ezetimibe works by decreasing cholesterol absorption in the intestines. [5] Ezetimibe was approved for medical use in the United States in 2002. [4] It is available as a generic ...

  3. Cholesterol absorption inhibitor - Wikipedia

    en.wikipedia.org/wiki/Cholesterol_absorption...

    Managing cholesterol at the site of absorption is an increasingly popular strategy in the treatment of hypercholesterolemia [citation needed].Cholesterol absorption inhibitors are known to have a synergistic effect when combined a class of antihyperlipidemics called statins, to achieve an overall serum cholesterol target.

  4. Bempedoic acid/ezetimibe - Wikipedia

    en.wikipedia.org/wiki/Bempedoic_acid/ezetimibe

    The most common side effects are hyperuricemia (high blood levels of uric acid) and constipation. [ 2 ] Bempedoic acid is an adenosine triphosphate-citrate lyase (ACL) inhibitor and ezetimibe is a cholesterol absorption inhibitor . [ 1 ]

  5. Statin - Wikipedia

    en.wikipedia.org/wiki/Statin

    The most important adverse side effects are muscle problems, an increased risk of diabetes mellitus, and increased liver enzymes in the blood due to liver damage. [ 5 ] [ 65 ] Over 5 years of treatment statins result in 75 cases of diabetes, 7.5 cases of bleeding stroke , and 5 cases of muscle damage per 10,000 people treated. [ 34 ]

  6. Pravastatin - Wikipedia

    en.wikipedia.org/wiki/Pravastatin

    Absorption of drug is modestly decreased when taken with food however this does not reduce the clinical lipid-lowering effect. [1] The 3α-hydroxyisomeric metabolite of pravastatin is also an active HMG-CoA reductase inhibitor with approximately 2.5-10% the potency of the parent compound.

  7. Lipid-lowering agent - Wikipedia

    en.wikipedia.org/wiki/Lipid-lowering_agent

    It decreases LDL by 15–30% and raises HDL by 3–5%, with little effect on triglycerides, but can cause a slight increase. Bile acid sequestrants may cause gastrointestinal problems and may also reduce the absorption of other drugs and vitamins from the gut. Ezetimibe is a selective inhibitor of dietary cholesterol absorption.